Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “asthma” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 226
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 226 pipeline programs matching "asthma" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

226 results for “asthma” Back to intelligence hub

Search results

Page 3 of 10
  1. FpA-AS-30093

    Lacuna Pharma Pty Ltd

    Asthma

    phase 3 small molecule active

    1 trial
  2. FpA-AS-30094

    Lacuna Pharma Pty Ltd

    Asthma

    phase 3 small molecule active

    1 trial
  3. GB-0895

    Generate Biomedicines

    Severe Asthma

    phase 3 small molecule active

    2 trials
  4. GW685698/GW642444

    GlaxoSmithKline

    Asthma

    phase 3 small molecule completed

    1 trial
  5. Generic Budesonide/Formoterol Fumarate Dihydrate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial
  6. Placebo

    Camp4 Therapeutics Corp

    Asthma

    phase 3 small molecule completed

    1 trial
  7. Placebo

    Amneal Pharma Europe Ltd

    Asthma

    phase 3 small molecule active

    1 trial
  8. Placebo

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial
  9. Placebo MDPI

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    3 trials
  10. Placebo Spiromax

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule terminated

    1 trial
  11. QAW039

    Novartis Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial
  12. QAW039 150 mg

    Novartis Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial
  13. QMF149

    Novartis Pharmaceuticals

    Asthma

    phase 3 small molecule active

    1 trial
  14. QMF149 150/80 μg

    Novartis Pharmaceuticals

    Mild Asthma

    phase 3 small molecule completed

    1 trial
  15. QVM149

    Grace Therapeutics

    Asthma

    phase 3 small molecule terminated

    1 trial
  16. QVM149 150/50/160

    Novartis Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial
  17. Reslizumab

    Teva Pharma GmbH

    Eosinophilic Asthma

    phase 3 small molecule completed

    5 trials
  18. Reslizumab

    Teva Pharma GmbH

    Severe Persistent Asthma

    phase 3 mab completed

    1 trial
  19. Reslizumab

    Teva Generics B.V

    Eosinophilic Asthma

    phase 3 small molecule terminated

    1 trial
  20. Roflumilast

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial
  21. SAN-1138

    Sandoz Pty Ltd

    Asthma

    phase 3 small molecule active

    1 trial
  22. Salbutamol HFA-134a

    GlaxoSmithKline

    Asthma

    phase 3 small molecule completed

    1 trial
  23. Symbicort Turbuhaler

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial
  24. TEV-56248

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule active

    2 trials

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.